Menu

Nico AD

Levallois-Perret

En résumé

Mes compétences :
Industrie pharmaceutique
Pharmacien
Qualité
Stratégie

Entreprises

  • Sandoz - Head Program Management Steriles and Special Technologies

    Levallois-Perret 2015 - maintenant Responsible for managing Steriles & New Technologies network (7 sites) projects to achieve a competitive advantage in all aspects of Technical Operations (strategy & execution) including supporting cross-divisional activities, generates synergies and financial benefits across Novartis divisions.

  • Sandoz - Project Manager Sterile forms (Manufacturing Science & Technology)

    Levallois-Perret 2014 - 2014 Kundl, Austria
    As part of the Technical Operations MS&T group, responsible for project management to further improve efficiency and compliance.
    Successful development and implementation of a site strategy in regards to visual inspection life cycle for sterile powder filling operations (taskforce leader)
    - Strategy setting and cross site alignment – Cross functional task force
    - Subject matter expert for visual inspection during FDA inspection and customers audits
    - Communication to Global stakeholders (commercial operation, TechOps, Quality) and external customers
    - Develop partnership with supplier to ensure continuous improvement
    Lead root cause investigations for sterile products (e.g. sampling, testing, manufacturing)

  • Sandoz - Regional TechOps QA Head Middle East Turkey and Africa

    Levallois-Perret 2012 - 2014 Setting site specific strategies for the 4 sites in the region, to align them to the Corporate strategy.
    Team of about 200 quality professionals across the 4 sites.
    Successful significant GMP upgrade going through organizational and process changes, leading to successful GMP audit outcomes supporting business growth.
    Active presence at the site level to drive cultural changes at the same time as driving GMP improvements.
    Site priority #1 has been remediated in only 8 month.

  • Novartis Animal Health Inc. - Director Global Quality R&D

    RUEIL MALMAISON 2009 - 2012 Setting site specific strategies for the 4 sites in the region, to align them to the Corporate strategy.
    Team of about 200 quality professionals across the 4 sites.
    Successful significant GMP upgrade going through organizational and process changes, leading to successful GMP audit outcomes supporting business growth.
    Active presence at the site level to drive cultural changes at the same time as driving GMP improvements.
    Site priority #1 has been remediated in only 8 month.

  • Novartis Santé Animale S.A.S - Pharmacien responsable et responsable qualité (AQ/CQ)

    2005 - 2009 Gestion des départements Assurance qualité, contrôle qualité et validation
    Massive site GMP upgrade which led to a successful FDA pre-approval inspection with no finding.
    Quality unit complete reorganization, development and alignment:
    - Creation of the shop floor QA unit in 2007 to ensure close partnership between QA and production
    - Incorporation and development of the validation department within the Quality Unit
    - Complete QC reorganization
    Site extension: pilot plant for scale up, new QC lab (new building and activity transfer without interruption

  • Bristol- Myers Squibb - Responsable contrôle qualité

    Rueil-Malmaison cedex 2002 - 2005

Formations

Réseau

Annuaire des membres :